Valproic Capsule, Liquid Filled
NDC Package 0591-4012-01
Package Information
Valproic (valproic acid) capsules is a medication used to treat seizure disorders, mental/mood conditions (such as manic phase of bipolar disorder), and to prevent migraine headaches. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Actavis Pharma, Inc., this product is identified by NDC 0591-4012 and is authorized under FDA application ANDA073229.
Identification & Billing
- RxCUI: 1099681 - valproic acid 250 MG Oral Capsule
- RxCUI: 1099681 - VPA 250 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0591 - Actavis Pharma, Inc.
- 0591-4012 - Valproic
- 0591-4012-01 - 100 CAPSULE, LIQUID FILLED in 1 BOTTLE
- 0591-4012 - Valproic
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0591-4012-01 identifies a specific commercial package of 100 capsule, liquid filled in 1 bottle of Valproic, a human prescription drug labeled by Actavis Pharma, Inc.. This capsule, liquid filled is formulated for oral use and contains valproic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Actavis Pharma, Inc. on September 08, 2009. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat seizure disorders, mental/mood conditions (such as manic phase of bipolar disorder), and to prevent migraine headaches. It works by restoring the balance of certain natural substances (neurotransmitters) in the brain.
How is this Actavis Pharma, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00591401201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.